Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Applied Genetic Technologies Corp    AGTC

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Applied Genetic Technologies Corp (NASDAQ:AGTC) reported earnings of ($0.18) per share missing Walls Streets expectations.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/13/2017 | 03:43pm CEST

Applied Genetic Technologies Corp (NASDAQ:AGTC) reported Q4 2017 earnings this Morning, coming in at ($0.18) per share, missing Wall Street’s estimates of $0.14 per Share. Revenue for the quarter came in at $8.30 million beating analyst estimates of $12.39 million

Analyst Coverage For Applied Genetic Technologies Corp (NASDAQ:AGTC)
These are 3 Hold Ratings, 6 Buy Ratings .
The current consensus rating for Applied Genetic Technologies Corp (NASDAQ:AGTC) is Buy (Score: 2.67) with a consensus target price of $14.63 , a potential (195.45% upside)Recent Insider Trading for Applied Genetic Technologies Corp (NASDAQ:AGTC)

  • On 11/16/2016Ivana Magovcevic, Director, bought 3,000 with an average share price of $9.63 per share and the total transaction amounting to $28,890.00.
  • On 11/1/2016 Jeffrey D Chulay, VP, sold 1,000 with an average share price of $7.05 per share and the total transaction amounting to $7,050.00.
  • On 9/22/2016 Mark S Shearman, Insider, bought 3,000 with an average share price of $8.87 per share and the total transaction amounting to $26,610.00.
  • On 9/20/2016 Stephen W Potter, Insider, bought 1,400 with an average share price of $8.89 per share and the total transaction amounting to $12,446.00.
  • On 9/19/2016 Lawrence E Bullock, CFO, bought 10,000 with an average share price of $8.75 per share and the total transaction amounting to $87,500.00.
  • On 2/23/2015 Plc Glaxosmithkline, Major Shareholder, sold 503,150 with an average share price of $22.00 per share and the total transaction amounting to $11,069,300.00.

    Recent Trading for Applied Genetic Technologies Corp (NASDAQ:AGTC) Shares of Applied Genetic Technologies Corp closed the previous trading session at with shares trading hands.

    The post Applied Genetic Technologies Corp (NASDAQ:AGTC) reported earnings of ($0.18) per share missing Walls Streets expectations. appeared first on Market Exclusive.

    © Market Exclusive 2017, source Market Exclusive

    share with twitter share with LinkedIn share with facebook
    share via e-mail
    0
    Latest news on APPLIED GENETIC TECHNOLOGI
    09/20 AGTC to Present at Upcoming Conferences
    09/14 APPLIED GENETIC TECHNOLOGIES CORPORA : AGTC) Files An 8-K Results of Operations ..
    09/13 APPLIED GENETIC TECHNOLOGIES CORP : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINA..
    09/13 APPLIED GENETIC TECHNOLOGIES CORP (N : AGTC) reported earnings of ($0.18) per sh..
    09/13 APPLIED GENETIC TECHNOLOGIES : posts 4Q loss
    09/13 APPLIED GENETIC TECHNOLOGIES CORP : Results of Operations and Financial Conditio..
    09/13 AGTC Announces Financial Results and Business Update for the Quarter and Fisc..
    09/08 APPLIED GENETIC TECHNOLOGIES CORP - : Management's discussion and analysis of f..
    09/06 APPLIED GENETIC TECHNOLOGIES : AGTC Appoints Matthew Feinsod, M.D. as Interim Ch..
    09/05 AGTC Appoints Matthew Feinsod, M.D. as Interim Chief Medical Officer
    More news
    News from SeekingAlpha
    09/14 Premarket analyst action - healthcare
    09/13 Midday Gainers / Losers
    09/13 Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q4 2017 Results - Earn..
    09/13 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
    09/13 Applied Genetic reports Q4 results
    Financials ($)
    Sales 2018 36,0 M
    EBIT 2018 -20,5 M
    Net income 2018 -17,2 M
    Debt 2018 -
    Yield 2018 -
    P/E ratio 2018 -
    P/E ratio 2019
    Capi. / Sales 2018 1,84x
    Capi. / Sales 2019 2,08x
    Capitalization 66,0 M
    Chart APPLIED GENETIC TECHNOLOGI
    Duration : Period :
    Applied Genetic Technologi Technical Analysis Chart | AGTC | US03820J1007 | 4-Traders
    Technical analysis trends APPLIED GENETIC TECHNOLOGI
    Short TermMid-TermLong Term
    TrendsBearishBearishBearish
    Income Statement Evolution
    Consensus
    Sell
    Buy
    Mean consensus OUTPERFORM
    Number of Analysts 8
    Average target price 8,63 $
    Spread / Average Target 136%
    EPS Revisions
    Managers
    NameTitle
    Susan B. Washer President, Chief Executive Officer & Director
    William A. Sullivan Chief Financial Officer
    Mark S. Shearman Chief Scientific Officer & Vice President
    Matthew Feinsod Chief Medical Officer
    James Rosen Independent Director
    Sector and Competitors
    1st jan.Capitalization (M$)
    APPLIED GENETIC TECHNOLOGIES CORP-60.96%66
    AMGEN27.65%135 544
    CELGENE CORPORATION24.22%112 572
    GILEAD SCIENCES15.37%108 744
    REGENERON PHARMACEUTICALS18.08%46 367
    VERTEX PHARMACEUTICALS106.41%38 136